Singh et al., 2023 - Google Patents
Pyrazole scaffolds having promising pharmacological potential: a reviewSingh et al., 2023
- Document ID
- 1279787067674978077
- Author
- Singh S
- Tehlan S
- Kumar Verma P
- Publication year
- Publication venue
- Mini Reviews in Medicinal Chemistry
External Links
Snippet
Heterocyclic compounds have diverse structure, which makes them broad and economical therapeutic agents. Pyrazole is a five-membered aromatic ring that contains two nitrogen atom and is responsible for the diverse functions of heterocyclic compounds. This implies …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vaidya et al. | 1, 3, 4‐oxadiazole and its derivatives: A review on recent progress in anticancer activities | |
Kumar et al. | Pyrazole scaffold: a remarkable tool in the development of anticancer agents | |
Faria et al. | Recently reported biological activities of pyrazole compounds | |
Sathyanarayana et al. | Exploring recent developments on 1, 2, 4‐triazole: Synthesis and biological applications | |
Vaidya et al. | Synthesis and biological activities of oxadiazole derivatives: a review | |
Maddila et al. | 1, 2, 4-Triazoles: A review of synthetic approaches and the biological activity | |
Naim et al. | Current status of pyrazole and its biological activities | |
Jamwal et al. | A review on pyrazole derivatives of pharmacological potential | |
Küçükgüzel et al. | Recent advances bioactive 1, 2, 4-triazole-3-thiones | |
Singh et al. | Pyrazole scaffolds having promising pharmacological potential: a review | |
Karati et al. | Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design | |
Abdelrehim | Synthesis and screening of new [1, 3, 4] oxadiazole,[1, 2, 4] triazole, and [1, 2, 4] triazolo [4, 3-b][1, 2, 4] triazole derivatives as potential antitumor agents on the colon carcinoma cell line (HCT-116) | |
Tabassum et al. | Imidazole and pyrazole: Privileged scaffolds for anti-infective activity | |
Guo et al. | Metal-and oxidant-free green three-component desulfurization and deamination condensation approach to fully substituted 1 H-1, 2, 4-triazol-3-amines and their photophysical properties | |
Ashour et al. | Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents | |
Kumar et al. | Synthetic methods and antimicrobial perspective of pyrazole derivatives: An insight | |
Singh et al. | 2-Pyrazolines as biologically active and fluorescent agents, an overview | |
Ashour et al. | Synthesis of some (E)-6-[2-(furan-2-yl) ethenyl]-1, 2, 4-triazin-5-ones and their biological evaluation as antitumor agents | |
Asif | Pharmacologically potentials of hydrazonone containing compounds: A promising scaffold | |
Alam et al. | Design, synthesis and cytotoxicity evaluation of pyrazolyl pyrazoline and pyrazolyl aminopyrimidine derivatives as potential anticancer agents | |
Zabiulla et al. | Recent investigation on heterocycles with one nitrogen [piperidine, pyridine and quinoline], two nitrogen [1, 3, 4-thiadiazole and pyrazole] and three nitrogen [1, 2, 4-triazole]: a review | |
Alghamdi et al. | A mini-review on pyridazine analogs: Chemical and pharmacological potentials | |
Singh et al. | Chemistry and pharmacological activities of pyrazole and pyrazole derivatives: A review | |
Shabana et al. | Review on the discovery of new benzimidazole derivatives as anticancer agents: synthesis and structure-activity relationship (2010-2022) | |
Alharbi et al. | Synthesis, chemical reactivities, and biological properties of pyrazolone/pyrazolinone as a blocking unit for building various heterobicyclic systems: a review |